Travere Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for patients with rare diseases. Headquartered in San Diego, California, Travere leverages a robust pipeline aimed at addressing significant unmet medical needs, particularly in the fields of metabolic and genetic disorders. The company's commitment to transforming the lives of patients is underscored by its strategic partnerships and development programs designed to bring effective therapies to market swiftly and efficiently.
Click "Analyze" to generate stock analysis
TVTX Price Trend and Signals
TVTX Option Volumes & Open Interests (aggregated)
TVTX Put Call Ratios and IV (aggregated)
TVTX Financials
2025-10-29Somewhat Bullishprice_signal
Yearly high detected.
2025-10-28Somewhat Bullishprice_signal
Yearly high detected.
2025-10-27Somewhat Bullishprice_signal
Yearly high detected.
2025-10-27Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-27Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-27Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-27Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.